These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 170227)
21. Methadone in a 30-day detoxification program for narcotic addicts: a critical review. Canada AT Int J Addict; 1972; 7(4):613-7. PubMed ID: 4349422 [No Abstract] [Full Text] [Related]
22. [Management of opium addicts using opiates and their antagonists]. Burchard JM Nervenarzt; 1972 Oct; 43(10):501-4. PubMed ID: 4564819 [No Abstract] [Full Text] [Related]
23. A controlled comparison of cyclazocine and naloxone treatment of the paroled narcotic addict. Hanlon TE; McCabe OL; Savage C; Kurland AA Int Pharmacopsychiatry; 1975; 10(4):240-50. PubMed ID: 765293 [TBL] [Abstract][Full Text] [Related]
24. A unit for delivering multiple drug treatment and prevention services. Hosp Community Psychiatry; 1975 Oct; 26(10):663-6. PubMed ID: 1201850 [TBL] [Abstract][Full Text] [Related]
25. Naltrexone and cyclazocine. A controlled treatment study. Brahen LS; Capone T; Wiechert V; Desiderio D Arch Gen Psychiatry; 1977 Oct; 34(10):1181-4. PubMed ID: 911218 [TBL] [Abstract][Full Text] [Related]
26. Cyclazocine in the treatment of opiate addiction: a review with recommendations. Goldstein MJ Int J Addict; 1980 Oct; 15(7):939-56. PubMed ID: 6256300 [TBL] [Abstract][Full Text] [Related]
27. Cyclazocine treatment of opiate dependence: a progress report. Resnick RB; Fink M; Freedman AM Compr Psychiatry; 1971 Nov; 12(6):491-502. PubMed ID: 5117068 [No Abstract] [Full Text] [Related]
28. Treatment of heroin addiction. Multimodality approach. Kissin B; Sang E N Y State J Med; 1973 May; 73(9):1059-65. PubMed ID: 4512163 [No Abstract] [Full Text] [Related]
29. Pharmacological adjuncts in the treatment of opiate dependence. Resnick RB Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422 [No Abstract] [Full Text] [Related]
30. On understanding and treating narcotic dependence: a neuropsychopharmacological perspective. Ng LK; Szara S; Bunney WE Br J Addict Alcohol Other Drugs; 1975 Sep; 70(3):311-24. PubMed ID: 1059467 [No Abstract] [Full Text] [Related]
31. Effects of cyclazocine on cocaine self-administration in rats. Glick SD; Visker KE; Maisonneuve IM Eur J Pharmacol; 1998 Sep; 357(1):9-14. PubMed ID: 9788768 [TBL] [Abstract][Full Text] [Related]
32. Rehabilitation of the heroin addict. Conrad HT Arch Invest Med (Mex); 1974; 5 SUPPL 1():223-34. PubMed ID: 4447421 [No Abstract] [Full Text] [Related]
33. Pharmacotherapy of opiate addiction. Swanson DA S Afr Med J; 1976 May; 50(22):857-9. PubMed ID: 935974 [TBL] [Abstract][Full Text] [Related]
34. A history of the development of narcotic antagonists for the treatment of narcotic addiction. Martin WR NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106 [No Abstract] [Full Text] [Related]
36. Psychopathology and mood during heroin use: acute vs chronic effects. Mirin SM; Meyer RE; McNamee HB Arch Gen Psychiatry; 1976 Dec; 33(12):1503-8. PubMed ID: 999452 [TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists. Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122 [TBL] [Abstract][Full Text] [Related]
38. Narcotic antagonists: new methods to treat heroin addiction. Hammond AL Science; 1971 Aug; 173(3996):503-6. PubMed ID: 5564039 [No Abstract] [Full Text] [Related]
39. Personality factors and drug effects in a controlled study of cyclazocine. Capone T; Brahen LS; Wiechert V J Clin Psychol; 1976 Apr; 32(2):489-95. PubMed ID: 770508 [TBL] [Abstract][Full Text] [Related]
40. Clinical studies of cyclazocine in the treatment of narcotic addiction. Freedman AM; Fink M; Sharoff R; Zaks A Am J Psychiatry; 1968 May; 124(11):1499-504. PubMed ID: 4869436 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]